“Highlights in therapy-related myeloid neoplasms” – tMN2023 – is a hybrid meeting. Participation is possible on line or in person. There is a limited number of places available to those who intend to take part in person, while on line participation is open and is guaranteed to all registered scientists.
Registration is free of charge and is mandatory. In person participation deadline is November 30, 2022. On line participation deadline is January 30, 2023. When register please indicate your choice whether on line or in person and you will receive an e-mail confirmation.
Technical facilities will enable participants to take part in the discussions easily and at any moment: slido.com interaction tools or similar will be used in addition to the chat function of the online conferencing system. Among the online participants, speakers will also be included.
Please note, in Day 2 of the meeting the Session Selected abstract presentations by early career scientists will take place. Early career scientists (below the age of 40) can send their abstracts once they register. Abstracts should be submitted by the presenting authors only. Together with the Registration confirmation you will receive the link to the page with the instructions to send your abstract in word format.
Abstract submission deadline is December 15, 2022. The organisers will then review the received abstracts for oral presentations.
A limited number of travel and accommodation grants are available to scientists whose abstract is selected for oral presentation.
- Title. The title must start in uppercase and continue in lowercase, except for conventional terms (ATP, DNA, NFκB, etc). Example:
This title is written correctly
This Title is Not Properly Written
ALSO THIS TITLE IS WRONG
- Authors. Presenting author name and surname are in full; for any other author(s) use initial(s) for the first name(s) followed by the surname. Don’t use “and” before the last author. If more than one affiliation (but only in that case), use sequential superscript numbers to identify each institution. Example:
Gabriele Lo Iudice1, E. De Bellis2, A. Savi1,2
1SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
2Department of Onco‑Hematology, Policlinico Tor Vergata, Rome, Italy
Abstract text. Keep the abstract text to within 2000 characters, spaces included (which is roughly equivalent to 250 words). For your text use CALIBRI font 12, line spacing 1.
- Bibliography is not included in the word count. Please, use Elsevier Harvard style. Examples:
Campisi, J., Kapahi, P., Lithgow, G.J., Melov, S., Newman, J.C., Verdin, E., 2019. From discoveries in ageing research to therapeutics for healthy ageing. Nature 571, 183–192. https://doi.org/10.1038/s41586-019-1365-2.
Chaib, S., Tchkonia, T., Kirkland, J.L., 2022. Cellular senescence and senolytics: the path to the clinic. Nat Med 28, 1556–1568. https://doi.org/10.1038/s41591-022-01923-y.